Type 2 Diabetes

Flu increases the risk of heart attack, especially among people with diabetes and atherosclerotic cardiovascular disease (ASCVD). COVID-19 and the possibility of co-infection makes getting vaccinated against the flu particularly important this year.

Drugs block the formation of tiny blood vessels in the retina that are prone to breaking open, resulting in bleeds that can cause serious vision impairment and blindness, explains ADA chief scientific and medical officer, Robert Gabbay, in this conclusion of a four-part video series.

Three healthcare organizations provide models for managing the disease and keeping a close eye on the bottom line.

Patients with diabetic macular edema whose vision remains impaired even with the best available treatments may soon have a combination therapy.

Results from REDUCE-IT trial presented at the ADA meeting show that the fish-oil pill is associated with cardiovascular disease protection among patients with diabetes.

Association of Diabetes Care and Education Specialists, chief science and practice officer, Leslie Kolb chats with MHE Associate Editor Briana Contreras in MHE's newest podcast Tuning into the C-Suite about diabetes management and how it's affected by the use of telehealth, especially during the current and trying times of the COVID-19 pandemic.

Immediately after the FDA said it found elevated levels of the carcinogenic ingredient N-nitrosodimethylamine (NDMA) in certain extended release (ER) metformin products, the first 2 major recalls are underway.

Americans have been diagnosed with diabetes, mostly with the type 2 variety linked with being overweight or obese.

Several Blues plans have contracted with vendors that supply tech-enabled diabetes disease management and prevention programs. Sometimes the tech is combined with coaching - by a real, live human being.

New plan from CVS Caremark eliminates member cost as a barrier to medications without raising costs for benefits, premiums or deductibles.

A survey of diabetes educators reveals challenges faced by patients with diabetes who can’t afford their drugs.

As people with type 2 diabetes age, the risks of insulin use can outweigh its benefits, creating the need for increased provider and patient education.

Study uncovers specific areas of care that cause concern for Americans with diabetes and opportunities for developing a plan of action.

Downturn in incidence may be partially due to successful public health campaigns to prevent the disease.

How the first oral GLP-1 oral treatment for type 2 diabetes is unique and how it will be priced compared to other GLP-1 medications.

Offering rewards can be a great way to increase member engagement for patients with diabetes.

FDA approved the first and only ready-to-use insulin for IV infusion in hospitals and acute care settings.

FDA granted Fast Track designation to a popular diabetes drug to reduce the risk of cardiovascular death and hospitalization for heart failure in people with chronic heart failure.

While aggressive early intervention may be useful for diabetes patients, that intervention must be sustained.

The leading problems that endocrinologists and educators see from their daily interactions with diabetes patients.

The prevalence of diagnosed diabetes in the United States has remained stable during the past eight years, even as obesity rates climb.

How new technologies are helping patients with diabetes better manage the disease.